|
|
| Phases of Development | Preclinical | Phase I | Phase II | Pivotal | Phase III | Registration | Approved | Marketed |
|---|
| Autoimmune | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 9 | | Cardiovascular | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Dermatology | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | | Endocrine / Metabolic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Gastrointestinal | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Infectious | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Inflammation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | | Musculoskeletal | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Neurology | 4 | 2 | 1 | 0 | 1 | 0 | 1 | 11 | | Ophthalmic | 0 | 1 | 1 | 0 | 1 | 0 | 2 | 1 | | Renal | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Cyclooxygenases (COX)